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“The only reason for time is so that everything doesn’t happen at once” 
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ABSTRACT 
Highly available, noninvasive and cost-effective, echocardiography remains a keystone 
in the evaluation of patients with coronary artery disease (CAD). Echocardiographic 
assessment of cardiac function at rest and during dobutamine stress has direct clinical 
implications. Conventional echocardiographic parameters however, are partly based on 
visual interpretation of cardiac motion, thereby subject to interobserver variability, 
especially in patients with poor image quality. As a complement, myocardial velocity 
imaging techniques such as Doppler tissue imaging (DTI) offer quantitative markers of 
cardiac function.  
In the present study, we explored the feasibility and diagnostic value of DTI in the 
evaluation of left and right ventricular function, the presence of inducible ischemia and 
myocardial viability in patients with ST-elevation myocardial infarction (STEMI). 
In 90 patients with STEMI (64 men and 26 women aged 65±13 years) 
echocardiography was performed at day 1, 5–7 days and 6 months after admission. At 
day 5–7, dobutamine stress echocardiography (DSE) with wall motion analysis (WMA) 
was performed, followed by coronary angiography within 24 hours. Using DTI, 
systolic, early and late diastolic myocardial velocities were recorded near the mitral 
annulus at 4 left ventricular (LV) sites, and near the tricuspid annulus in the right 
ventricular free wall. The myocardial performance index (MPI), a Doppler-based, 
combined measure of systolic and diastolic function, was calculated as the sum of the 
isovolumic time intervals divided by the ejection time derived from DTI at the 4 LV 
sites. Forty-one aged-matched healthy subjects served as controls. 
In patients with complete normalization of conventional parameters of LV function 
at follow-up, peak systolic as well as early diastolic LV myocardial velocities were 
significantly reduced compared with those in healthy subjects, possibly reflecting a 
residual subendocardial damage.  
Using peak systolic velocity in the right ventricular (RV) free wall as a marker of 
RV function, sensitivity and specificity of DTI in identifying patients with 
electrocardographic signs of RV infarction (ST-elevation in ECG lead V4R) were 89% 
and 71%, respectively. Furthermore, peak RV systolic velocities remained reduced in 
patients with RV infarction, even after resolution of ECG changes and were still 
evident at 6 months’ follow-up.  
Use of the MPI as a marker of ischemia during DSE was shown to be feasible, and 
although the majority of patients did not achieve an optimal level of stress, relative 
changes in MPI between rest and peak stress offered reasonable diagnostic properties, 
superior to those of WMA. Sensitivity and specificity for detection of left anterior 
descending, left circumflex and right coronary artery disease were 80% and 87%, 59% 
and 80% and 85% and 72%, respectively. 
Finally, we found that MPI during low-dose dobutamine infusion exhibits a specific 
pattern, similar to that of WMA, predicting late recovery of LV systolic function.  
In conclusion, the use of DTI during echocardiography at rest and during 
dobutamine stress is feasible and allows evaluation of LV and RV function in the acute 
as well as the late phase after a STEMI. Furthermore, changes in MPI derived from 
DTI during DSE identify patients with residual CAD and predict late recovery of LV 
function, independently of age, troponin level and time to reperfusion treatment.  
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INTRODUCTION 
CORONARY ARTERY DISEASE 
Coronary artery disease (CAD) is a leading cause of death and a major cause of 
morbidity in the western world. Risk factors include age, heredity, obesity, physical 
inactivity, smoking and the presence of diabetes mellitus, hypertension and 
dyslipidemia. New therapeutic options for prevention and treatment of CAD have 
resulted in an increasing number of patients surviving a cardiovascular event. The 
positive effects of new therapies however, are at least partly outweighed by the 
increasing incidence in the aging population [1]. 
Pathophysiology and clinical spectrum 
Early mechanisms initiating the process of atherosclerosis precede clinical 
manifestations of coronary artery disease by decades [2]. A complex process where 
deposition and oxidation of lipids is accompanied by endothelial dysfunction, 
infiltration of inflammatory cells and proliferation of smooth muscle cells and fibrous 
tissue results in progressively increasing plaque, consisting of a lipid core with a 
fibrous cap (Fig. 1). An initial outward growth of the atherosclerotic plaque, commonly 
referred to as positive remodeling, is followed by inward growth, compromising the 
vessel lumen, ultimately limiting coronary blood flow.  
When the balance between metabolic demands and oxygen delivery is shifted during 
exercise, myocardial ischemia is induced, either silent or clinically manifested as stable 
angina pectoris. Symptoms are typically evoked by a certain level of exertion, ranging 
from mild to strenuous exercise. 
A combination of mechanical forces from coronary blood flow and degradation of 
collagen and other matrix proteins in the fibrous cap may lead to rupture or fissuring of 
the atherosclerotic plaque, thereby exposing factors triggering coagulation and 
thrombus formation [3] (Fig. 1). The clinical manifestations include unstable angina 
pectoris, non ST-elevation and ST-elevation myocardial infarction (NSTEMI, STEMI), 
and sudden cardiac death. 
 
 
 
 
 
 
 
 
 
 
 
 
Atherosclerotic plaque 
 
 
Plaque rupture 
 
 
Thrombus formation 
Figure 1. Rupture of an atherosclerotic plaque with subsequent thrombus formation 
limiting coronary blood flow. 
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Medical treatment 
Treatment of CAD is based on modification of atherosclerosis progression, inhibition 
of thrombotic mechanisms and limitation of myocardial oxygen consumption. HMG-
CoA reductase inhibitors, known as statins, have been documented to slow the rate of 
atherosclerosis progression and lower the risk of myocardial infarction and death in 
patients with CAD [4]. Inhibitors of angiotensin-converting enzyme (ACE-inhibitors) 
also seem to reduce the risk of cardiac events, beyond the level of their antihypertensive 
effect [5]. Anti-ischemic medication, including beta-blocking agents, calcium channel 
inhibitors and nitrates, limit oxygen consumption through reduction of heart rate (HR), 
blood pressure (BP), preload and afterload. Antithrombotic treatment targets different 
mechanisms of coagulation, where platelet inhibition is a fundamental component in 
treatment of stable, as well as unstable CAD. Inhibition of the enzyme cyclooxygenase 
by aspirin, the ADP receptor by thienopyridines and the GP2b/3a receptor on the 
surface of platelets, all independently contribute to reduction of clinical events [6]. In 
order to counteract the prothrombotic mechanisms in unstable CAD, antiplatelet 
therapy is combined with anticoagulation, for many years represented by unfractionated 
heparin, later replaced by low-molecular-weight heparins and direct inhibitors of 
thrombin and factor X [7-9]. In patients with STEMI, the presence of a thrombus 
completely occluding a coronary vessel requires prompt actions to restore normal 
coronary blood flow, thereby limiting the extent of myocardial necrosis. The 
introduction of fibrinolytic agents offered specific means of reperfusion, improving 
prognosis in STEMI patients [10].  
Invasive treatment 
Since its introduction in 1960, coronary artery bypass surgery (CABG) has been 
considered the gold standard of revascularization for CAD, especially in patients with 
multivessel- and left main disease [11]. Technical progress in the field of percutaneous 
coronary intervention (PCI), however, now allows treatment of an increasing 
proportion of patients throughout the whole spectrum of CAD. Large-scale trials 
established the positive prognostic effects of an early invasive strategy in patients with 
NSTEMI [12]. Furthermore, for patients with STEMI, primary PCI has emerged as the 
reperfusion treatment of choice, at least in centers with close access to invasive 
facilities [13]. 
ANATOMICAL AND PHYSIOLOGICAL ASPECTS OF NORMAL LEFT AND 
RIGHT VENTRICLES 
Left and right ventricular geometry 
There are some distinct differences in the geometry of the two ventricles. The left 
ventricle (LV) is cylindrical or conical, with an almost circular cross-sectional shape. 
The three-dimensional structure of the anteriorly oriented right ventricle (RV) is more 
complex, having the shape of a modified ellipsoid with a semilunar short axis 
appearance (Fig. 2).  
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The muscular part of the ventricular wall (the myocardium) is arranged in 3 layers 
with different orientation. In the LV, the superficial layer is obliquely arranged with a 
spiral-like course from the base to the apex, whereas the mid-layer is circumferential, and 
the inner layer longitudinally oriented. This complex microstructure of the LV wall has 
important implications for normal ventricular contraction and relaxation. In contrast, the 
RV wall mainly consists of a superficial layer with circumferentially oriented muscle 
fibers and a deep layer, where fibers are longitudinally oriented. Despite these 
differences, there is continuity between the muscle layers of the right and left ventricular 
wall, resulting in functional interdependence between the two ventricles [14].  
 
 
 
 
 
 
 
 
 
 
 
 
 
The contractile unit 
Myocardial contraction and relaxation is based on function of the contractile units, or 
sarcomeres inside the cardiac myocytes. The sarcomere is a protein complex consisting 
of myosin and troponin, attached to thin actin filaments. The contractile process is 
initiated by an action potential releasing calcium ions from the sarcoplasmic reticulum. 
As a result of calcium binding, troponin changes shape, exposing binding sites for 
myosin at the actin filaments. This allows cross-bridging between myosin and actin, 
initiating contraction. Energy-dependent calcium ion reuptake into the sarcoplasmic 
reticulum results in decreasing intracellular calcium concentrations and reversal of the 
cross-bridging between myosin and actin filaments, thereby initiating myocardial 
relaxation [15].  
Mechanisms of left ventricular systolic contraction 
The systolic phase begins after closure of the mitral valve. Intraventricular pressure 
increases, initially without any volume change, representing the isovolumic contraction 
period. As the aortic valve opens, blood passes out into the aorta, representing the 
ejection period. Contraction in the different muscle layers of the myocardium causes a 
complex deformation pattern of the LV, resulting in volume reduction during systolic 
        RV                LV 
Figure 2. Schematic view of the interrelation between the right (RV) and left (LV) 
ventricles. (Kovalova S, Eur J Echocardiogr 2005;6:15-23) Reprinted with the 
permission of Oxford University Press. 
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ejection. Contraction of the obliquely oriented fibers of the superficial layer causes 
rotation and twisting of the LV, in opposite directions at the base and apex [16]. 
Circumferential and longitudinally oriented fibers are responsible for concentric radial 
compression and shortening of the LV by atrio-ventricular (AV) plane displacement 
[17]. The contribution of the individual directions of contraction to overall LV systolic 
function depends on several factors, including age, preload, afterload, heart rate and 
contractility [18, 19]. 
Left ventricular diastolic relaxation and filling 
Relaxation of the LV is an active, energy-requiring process, dependent on calcium 
reuptake into the sarcoplasmic reticulum. The diastolic phase begins with closure of the 
aortic valve. Similar to isovolumic contraction, there is an initial isovolumic period, 
followed by a rapid increase in LV volume during early filling. Rotation during systolic 
contraction resulting in increasing LV wall tension is reversed during diastole. 
Untwisting, or elastic recoil, results in suction of blood from the atrium into the LV 
[20]. During late diastole, atrial contraction contributes to the late phase of LV filling 
[21]. Factors determining the proportion of LV filling during early and late phases of 
diastole include the rate of myocardial relaxation, LV compliance and left atrial (LA) 
pressure [22].  
Right ventricular function 
As a result of serial connection, stroke volumes of the two ventricles are equal. 
However, in contrast to the LV, the RV is connected to a low-resistance vascular 
system, explaining some of its anatomical and physiological characteristics, including a 
thinner muscular wall and a lower systolic pressure compared with the LV. Diastolic 
filling of the RV depends on several factors, including heart rate, right atrial (RA) 
pressure and RV compliance. Right ventricular systolic contraction is a result of 
longitudinal shortening with AV-plane displacement, radial compression from the 
lateral free wall and interaction with LV contraction [23, 24]. Right ventricular 
contractility and stroke volume are mainly determined by loading conditions. Changes 
in RV preload (e.g. in dehydration) may have significant impact on stroke volume, 
resulting in low cardiac output and systemic hypotension. Furthermore, compared with 
the LV, the RV is more sensitive to changes in afterload and even a moderate increase 
in pulmonary vascular resistance may lead to a significant reduction of RV stroke 
volume [25].  
The coronary circulation 
Myocardial blood flow is supplied by the coronary arteries (Fig. 3). Two main vessels, 
the left coronary artery (LCA) and the right coronary artery (RCA) arise from the aorta, 
in the left and right sinus of Valsalva. The common take-off of the LCA, the left main 
stem, splits into the left anterior descending artery (LAD) and the left circumflex artery 
(LCx). Originating from the LAD, septal and diagonal branches supply the 
interventricular septum, the anterior and lateral wall of the LV, while obtuse marginal 
branches from the LCx mainly supply the lateral, posterolateral and posterior LV wall 
segments. Originating from the RCA, posterolateral (PLA) and posterior descending 
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(PDA) arteries supply LV posterolateral and inferior segments and the inferior 
interventricular septum. However, the anatomical distribution of the coronary 
circulation exhibits wide variation. According to the origin of the PDA, three main 
patterns may be distinguished, where right dominance is the most common (PDA 
originating from the RCA), followed by codominance and left dominance (PDA 
originating from the LCx). In a recent study using multislice computed tomography, the 
frequencies of right-, left- and codominance were 88.1%, 8.5% and 3.4%, respectively 
[26]. In a right dominant system, blood flow to the RV is mainly supplied by the RCA, 
where acute marginal branches supply the anterolateral wall and the PDA supplies the 
posterior and inferoseptal region, while branches from the LAD supply the apical 
segments of the RV. Furthermore, branches mainly from the RCA supply the sinoatrial 
node and the atrioventricular node of the conduction system, explaining the frequent 
occurrence of arrhythmias associated with acute occlusion of the RCA [27]. Anomalies 
of the coronary circulation are seen in approx. 1–1.5 % of the population. Most 
common anomalies include separate origin of the LAD and LCx from the aorta, ectopic 
origin of the LCx from the right coronary sinus and ectopic coronary origin from the 
posterior sinus of Valsalva [28]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
As a result of extravascular compression from the contracting myocardium during 
systole, coronary blood flow to the LV occurs predominantly during diastole (Fig. 4). 
In contrast, blood flow in the RCA is more homogeneously distributed over the cardiac 
cycle because of the thinner wall and lower systolic pressure of the RV. Coronary 
blood flow is regulated by intrinsic as well as by extrinsic mechanisms, including 
endothelium-derived vasoactive substances, circulating catecholamines and autonomic 
nervous tone [29]. By means of autoregulation, coronary blood flow is maintained at 
different levels of systemic blood pressure (BP), ranging from 60 to 200 mmHg (Fig. 4). 
 
 
 
Figure 3. Normal distribution of the coronary arteries 
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IMPACT OF ISCHEMIA ON LEFT AND RIGHT VENTRICULAR FUNCTION - 
PATHOPHYSIOLOGICAL AND CLINICAL ASPECTS 
The ischemic cascade 
In the presence of obstructive CAD, an increasing level of exercise results in coronary 
flow abnormalities, thereby shifting the balance between myocardial oxygen demand 
and delivery to an ischemic state. Similarly, rupture of an atherosclerotic plaque and 
thrombus formation in unstable CAD results in limitation or inhibition of regional 
coronary blood flow with subsequent induction of ischemia. A decrease in oxygen-
dependent production of adenosine triphosphate (ATP) ultimately causes impaired 
membrane transportation of calcium in the sarcoplasmic reticulum, thereby affecting 
the activation and deactivation of cross-bridges between myosin and actin filaments in 
the sarcomere. This impairment of the fundamental mechanisms of cardiac myocyte 
function is clinically manifested as diastolic and systolic dysfunction. In experimental 
studies it has been demonstrated that after induction of ischemia, regional diastolic 
dysfunction precedes changes in systolic function, followed by ECG changes and 
finally symptoms of angina [30, 31]. Thus, it is evident that the clinical presentation of 
myocardial ischemia is just the top of an iceberg consisting of the event chain initiated 
by coronary flow abnormalities. This is commonly referred to as the ischemic cascade 
[32] (Fig. 5). 
 
 
Figure 4. Blood flow in the left coronary artery – relationship to aortic pressure during 
systole and diastole. Reprinted with the permission of Richard E. Klabunde. 
www.CVphysiology.com 2009. 
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Left ventricular systolic function 
As early as in 1935 Tennant and Wiggers demonstrated the effects of coronary 
occlusion on regional LV systolic function [33]. Further studies established the almost 
linear relationship between regional myocardial blood flow and systolic contraction 
[34, 35]. Impaired regional systolic function is seen within seconds of coronary 
occlusion, followed by a return to normal function in less than a minute after restoration 
of blood flow [36]. If ischemia is prolonged, myocardial necrosis may occur, starting in 
the subendocardium where metabolic demands are higher and oxygen tension is lower 
compared with the subepicardial region [37]. Continued necrosis progresses towards 
the subepicardial myocardium, becoming transmural if myocardial perfusion is not 
restored. Experimental studies suggest that reduction in twisting and rotation of the LV 
may play an important role in ischemic systolic dysfunction [38]. This hypothesis is 
supported by results of in vivo studies in patients with MI [39]. The presence of 
inducible myocardial ischemia is a strong predictor of cardiac events, including 
mortality [40]. The risk increases with the extent of ischemia and the number of vessel 
territories involved [41]. Ischemic LV systolic dysfunction is clinically manifested as 
heart failure. Symptoms include shortness of breath, fatigue and fluid retention. The 
presence of left ventricular systolic dysfunction is a strong predictor of mortality in 
patients with CAD [42].  
Left ventricular diastolic function 
As previously discussed, diastolic dysfunction is an early manifestation of ischemia, 
preceding changes in systolic function as well as ECG changes and symptoms. 
Mechanisms of ischemia-induced diastolic dysfunction include reduced or delayed 
relaxation and untwisting as well as increased wall stiffness [43-45]. Asymptomatic LV 
diastolic dysfunction with preserved systolic function may be present in up to one third of 
patients with stable CAD, in whom the presence of moderate to severe diastolic 
dysfunction is a strong predictor of hospitalization for heart failure as well as for cardiac 
Figure 5. The classic ischemic cascade. 
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death [46]. In patients with chronic ischemic cardiomyopathy, diastolic function may 
improve after revascularization [47]. The prognostic implications of diastolic dysfunction 
in patients suffering from myocardial infarction (MI) have been established in several 
small studies, and confirmed in a recent meta-analysis showing an almost threefold 
increase in all-cause mortality in the presence of severe diastolic dysfunction [48].  
Stunning, hibernation and myocardial viability  
Although transient after short exposure to myocardial hypoperfusion, LV systolic 
dysfunction may be persistent after prolonged or repeated episodes of ischemia. This 
phenomenon, commonly referred to as myocardial stunning [49], has been extensively 
studied in animal models [50] as well as in a variety of clinical situations. Exercise-
induced ischemia may lead to LV systolic dysfunction evident even after resolution of 
ECG changes and symptoms [51]. In patients with acute myocardial infarction, systolic 
dysfunction may persist for weeks after successful reperfusion [52]. Thus, stunning is 
defined as persistent post-ischemic myocardial dysfunction in viable tissue despite 
restoration of normal myocardial perfusion. During the past 30 years, cellular and 
molecular mechanisms involved in myocardial stunning have been subject to intensive 
research, where interest has been focused on the effect of oxygen-derived free radicals 
and calcium regulation [53, 54].   
In contrast to the perfusion-function mismatch characterizing myocardial stunning, 
the combination of chronic hypoperfusion and myocardial dysfunction is the typical 
finding in hibernating myocardium. Introduced by Rahimtoola in 1985, the term 
myocardial hibernation has been frequently used to describe the adaptation of 
myocardial tissue to chronic hypoperfusion [55]. Micro-structural as well as metabolic 
changes have been demonstrated to play a role in the pathogenesis of hibernating 
myocardium [56]. Morphological abnormalities of cardiac myocytes, including loss of 
contractile units and alterations of the interstitial architecture are accompanied by 
accumulation of glycogen and increasing numbers of mitochondria with an abnormal 
shape [57]. Although experimental studies support the definition of myocardial 
stunning and hibernation as two distinct forms of ischemic myocardial dysfunction, 
there is probably some functional overlap, mainly regarding hibernation and repetitive 
stunning [58].  
A common characteristic of stunned and hibernating myocardium is the potential for 
recovery of contractile function, referred to as myocardial viability. By definition, 
functional recovery is spontaneous in stunning, but has to be preceded by 
revascularization and restoration of myocardial perfusion in hibernating myocardium. 
The presence of myocardial viability is a prognostic marker in patients with LV 
dysfunction and CAD, identifying patients who benefit from revascularization [59]. 
Moreover, there is a relationship between the extent of viable myocardium and the 
probability of functional recovery as well as the risk of future adverse events [60]. 
Right ventricular function 
Substantial interest has been directed towards the impact of ischemia on RV function. 
Experimental studies demonstrate that occlusion of the RCA is rapidly followed by RV 
dysfunction. However, in contrast to LV function, RV function is immediately 
improved by reperfusion after one hour of occlusion. In fact, global RV function may 
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recover without extensive residual infarction, even after several hours of coronary 
occlusion [61]. Differences in loading conditions, wall tension and thereby oxygen 
demand may partly explain why the RV is less sensitive to ischemic injury [62]. 
Furthermore, even if antegrade flow in the RCA is completely inhibited, RV 
myocardial perfusion may be supplied by branches from the LCA as well as by acutely 
developed collaterals [63]. In post-mortem studies, right ventricular involvement has 
been demonstrated in up to 60% of patients dying from posterior as well as anterior MI 
[64]. However, a minority of patients and exclusively those with posterior infarction, 
present with clinical manifestations of RV infarction, including jugular venous 
distention and systemic hypotension [65, 66]. Hemodynamic impairment may be even 
more pronounced in the presence of concomitant LV dysfunction or atrial fibrillation. 
The diagnosis of RV infarction is commonly based on clinical signs, 
electrocardiographic, echocardiographic or angiographic parameters [67, 68]. 
Treatment is focused on maintaining adequate RV preload and heart rate. Furthermore, 
reperfusion treatment is associated with a favorable short-term prognosis and results in 
rapid recovery of RV function. However, positive prognostic effects seem to depend 
specifically on successful reperfusion of RV branches [69]. The prognostic implications 
of RV infarction have been addressed in several studies, with conflicting results [70, 
71]. A recent meta-analysis, however, confirmed the prognostic value, showing a 
relative risk of death of 2.59 (95% CI 2.02–2.31, p<0.00001 in the presence of RV 
infarction [72].  
ECHOCARDIOGRAPHIC ASSESSMENT OF LEFT AND RIGHT 
VENTRICULAR FUNCTION IN THE NORMAL AND ISCHEMIC HEART 
Historical perspective 
The idea of using ultrasonographic imaging in medicine originated from industrial use 
of ultrasound to detect flaws in metal during the 1920s. The first ultrasonographic 
image of the heart was presented by the Swedish cardiologist Inge Edler and the 
German physicist Helmuth Hertz in 1953 (Fig. 6). Based on their pioneering work and 
the achievements in the field of computer technology during the following decades, 
echocardiography has evolved into an indispensable tool in modern cardiology, 
allowing real-time, high-resolution imaging for morphological as well as functional 
assessment of the heart. The application of Doppler techniques established 
echocardiography as the gold standard for evaluation of valvular heart disease, and also 
allowed the development of new quantitative methods for assessment of ventricular 
function based on myocardial tissue velocity imaging. For many years, the combination 
of echocardiography and stress testing, either pharmacologic or by means of physical 
exercise, has been a keystone in the evaluation of myocardial ischemia and viability. 
Finally, specific contrast agents developed for ultrasonographic imaging have improved 
image quality and extended the use of echocardiography to include the evaluation of 
myocardial perfusion. 
 
 10 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Assessment of left ventricular systolic function 
Left ventricular systolic function may be expressed in many different ways, including 
contractility, stroke volume and ejection fraction (EF), the latter frequently used in 
echocardiography. Although the clinical impact of changes in EF largely depends on 
loading conditions, the prognostic implications of LV systolic dysfunction expressed as 
EF are undisputed [73, 74]. Furthermore, LVEF is useful in selecting patients who 
would benefit from specific therapies such as cardiac resynchronization pacemakers 
and implantable cardioverter defibrillators [75].  
With the exception of three-dimensional imaging, echocardiographic methods for 
quantification of LVEF are based on assumptions of LV geometry. This has been 
considered as a major limitation of methods based on one-dimensional recordings of 
linear changes in LV dimensions, e.g. the Teichholz method, where geometrical 
assumptions ignore the influence of regional differences in systolic function [76]. 
Frequently used in clinical practice, estimation of LVEF by means of visual 
assessment, or eyeballing, has been shown to correlate to reference methods such as 
radionuclide imaging [77], but it is subject to significant interobserver variability, and 
is therefore inappropriate for serial evaluation [78]. The method of choice for 
quantification of LVEF recommended by the American Society of Echocardiography 
(ASE) is the biplane method of discs (also known as the modified Simpson’s method). 
End-systolic and end-diastolic volumes are estimated from apical 2-chamber and 4-
chamber views by dividing the LV into a number of elliptical discs and LVEF is 
calculated as the difference between end-diastolic and end-systolic volumes divided by 
the end-diastolic volume. Although new applications such as second harmonic imaging 
and the use of contrast agents have improved image quality, the accuracy of the biplane 
method of discs still depends on complete endocardial border definition. The evolution 
of 3D echocardiography has allowed the calculation of LV volumes independently of 
geometrical assumptions. Benefiting from this advantage, 3D echocardiography proved 
to be more accurate in determining LV volumes and EF when compared with 2D 
imaging [79, 80]. 
Figure 6. The first ultrasonographic image of the heart. 
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While assessment of LVEF is essential for evaluation of patients with heart failure 
and valvular heart disease, the localization and extent of regional changes in LV 
systolic function have important clinical implications for patients with CAD. 
Recommended by the ASE, a 16-segment model has become the gold standard for 
echocardiographic assessment of regional LV wall motion [81]. Each myocardial 
segment is assigned a wall motion score (1, normal; 2, hypokinesis; 3, akinesis and 4, 
dyskinesis) and the relationship between LV segments and the distribution of the 
coronary arteries allows the identification of culprit lesions in acute MI as well as in 
stable CAD (Fig. 7).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In order to overcome the limitations of suboptimal image quality, surrogate variables 
independent of volume calculations have been proposed for the estimation of LVEF. 
Left-ventricular long-axis displacement of the AV plane towards the apex is linearly 
correlated to LVEF by radionuclide angiography and a mean displacement of 10 mm or 
more is highly predictive of an EF of > 50% [82]. During the last two decades, 
parameters derived from myocardial velocity imaging techniques have been extensively 
used as markers of LV systolic function. These will be further discussed in subsequent 
sections. 
Figure 7. The 16-segment model for assessment of regional LV wall 
motion. (Becher H, Heart 2004;90:vi23-vi30) Reprinted with the 
permission of the BMJ Publishing Group Ltd. 
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Assessment of left ventricular diastolic function 
As previously discussed, left ventricular filling during diastole is a complex process 
involving passive as well as active mechanisms of the left atrium and ventricle. The 
multifactorial nature of LV diastolic function therefore constitutes a major challenge in 
echocardiographic evaluation of patients with heart disease. On the other hand, it 
allows the use of several different parameters reflecting ventricular filling, providing a 
more complete assessment of LV diastolic function. Alterations in LV morphology 
such as hypertrophy should raise the suspicion of diastolic dysfunction because of the 
frequent causal relationship. Conversely, an increase in left atrial (LA) volume is often 
a result of elevated LV filling pressures secondary to diastolic dysfunction, although 
other causes have to be considered. Pressure-related indices of LV diastolic function 
may also be derived from Doppler recordings of tricuspid and pulmonary valvular flow 
profiles. Thus, in the absence of increased pulmonary vascular resistance or severe 
pulmonary hypertension, pulmonary artery diastolic pressure derived from recordings 
of pulmonary regurgitation flow correlates to LA pressure, thereby reflecting LV 
diastolic function [83]. Based on the fundamental mechanics of LV filling, pulsed wave 
Doppler recordings of the flow profiles of early and late filling in combination with 
recordings of pulmonary venous flow are frequently used for the assessment of LV 
diastolic function (Fig. 8). At early stages of diastolic dysfunction, disturbances in LV 
relaxation are reflected by a shift in the proportion between early and late filling 
(commonly referred to as the ratio between mitral E and A waves, the E/A ratio) and a 
prolongation of the E wave deceleration time. With increasing severity of diastolic 
dysfunction and progressively increasing LV filling pressures, the contribution of left 
atrial contraction to LV filling decreases, thereby resulting in normalization of the 
mitral inflow profile and the E/A ratio (often referred to as pseudonormalization). 
Additional recordings while the patient is performing the Valsalva maneuver as well as 
recordings of pulmonary venous flow profiles often allow distinction between normal 
and pseudonormal filling patterns. The most severe form of diastolic dysfunction is 
characterized by a restrictive filling pattern with a high peak E velocity, a short E 
deceleration time and a high E/A ratio. Changes in the isovolumic relaxation time 
(IVRT) also reflect diastolic function. At early stages of diastolic dysfunction delayed 
LV relaxation results in prolongation of the IVRT, whereas a restrictive filling pattern 
is typically associated with a short IVRT. Although useful in many clinical situations, 
analysis of mitral inflow has to be interpreted with caution as the different components 
may be influenced by extrinsic factors such as loading conditions. Moreover, in the 
presence of tachy-arrythmias, especially atrial fibrillation and flutter, analysis of E/A 
ratio and E deceleration time may be impossible. In addition to transmitral flow 
patterns, assessment of intraventricular flow propagation by means of color M-mode 
recordings is useful in the evaluation of diastolic function. As a result of the decrease in 
relaxation-related suction force present in diastolic dysfunction, the pressure gradient 
between the LA and LV is diminished, thereby slowing flow propagation towards the 
apex. Especially when used in conjunction with mitral E velocity, flow propagation 
velocity is correlated to LV filling pressure [84]. Assessment of diastolic function is 
probably the most common clinical application of myocardial velocity imaging 
techniques such as Doppler tissue imaging (DTI). A decrease in peak early velocity is 
typically seen at all stages of diastolic dysfunction. This will be further discussed in a 
following section. 
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Assessment of right ventricular function 
Considering the complex geometry of the RV, it is obvious that accurate calculation of 
end-diastolic and end-systolic volumes from echocardiographic images would require 
advanced mathematical models not suitable for daily clinical practice. Nevertheless, 
changes in RV area between systole and diastole measured in the apical 4-chamber 
view, i.e. RV fractional area change (RVFAC), have been used as a surrogate for 
RVEF and have been shown to correlate well with RVEF as assessed by magnetic 
resonance imaging (MRI) [85]. By using three-dimensional echocardiography, RVEF 
may be assessed independently of volume assumptions, resulting in low variability and 
a high level of correlation with MRI [86]. However, RVFAC and 3D echocardiography 
are time-consuming and both methods depend on optimal image quality. Therefore, 
evaluation of RV function in daily practice is often based on visual assessment and 
simple surrogate parameters. Readily appreciated by means of visual assessment, 
alterations in RV morphology may reflect changes in RV contractility and afterload. 
Thus, a decrease in RV contractility resulting from a RVMI is frequently followed by 
dilatation and a change in shape of the RV. Analysis of tricuspid AV plane systolic 
excursion (TAPSE) in the RV lateral free wall offers a simple, quantitative surrogate 
parameter of RV function [87], also demonstrated to predict outcome in a variety of 
Figure 8. Left ventricular (LV) and left atrial (LA) pressures during diastole, transmitral 
Doppler LV inflow velocity, pulmonary vein Doppler velocity, and Doppler tissue 
velocity. A, velocity of LV filling contributed by atrial contraction; Am, myocardial 
velocity during filling produced by atrial contraction; Dec. Time, E-wave deceleration 
time; E, early LV filling velocity; Em, myocardial velocity during early filling; IVRT, 
isovolumic relaxation time; PVa, pulmonary vein velocity resulting from atrial 
contraction; PVd, diastolic pulmonary vein velocity; PVs, systolic pulmonary vein 
velocity; Sm, myocardial velocity during systole. (Leite-Moreira, Heart 2006;92:712-
718) Reprinted with permission of the BMJ Publishing Group Ltd. 
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clinical settings, including heart failure [88]. Finally, as previously discussed, the LV 
contributes significantly to RV function, mainly through septal interaction. Thus, 
simultaneous observation of LV performance is essential for a complete assessment of 
RV function.  
DOBUTAMINE STRESS ECHOCARDIOGRAPHY 
Detection of inducible ischemia is fundamental for risk assessment in patients with 
known or suspected CAD [89]. The choice of method for cardiac stress testing is based 
on multiple factors, including pre-test probability of disease, the patient’s ability to 
exercise and the need for ischemia-localizing information and assessment of viability 
[90]. Since being introduced in the 70s, stress echocardiography (SE) has evolved as 
one of the gold standard methods for detection of inducible myocardial ischemia and 
viability [91, 92]. Recently, SE was shown to provide incremental prognostic 
information, above that of clinical and exercise-ECG data in patients with suspected 
CAD [93]. The basic principle of SE is the demonstration of new wall motion 
abnormalities induced by myocardial ischemia which, in turn, may be achieved by 
physical exercise (bicycle or treadmill), pacing or pharmacological stress. Common 
agents used for pharmacological stress include the synthetic catecholamine dobutamine 
and vasodilators such as adenosine and dipyridamole. For the latter two, ischemia is 
induced by dilatation of vessels in the myocardial microcirculation resulting in a 
redistribution of flow from stenosed to non-stenosed coronary vessels. Dobutamine 
induces ischemia through β1-receptor stimulation, increasing heart rate, contractility 
and to a less extent systolic blood pressure. The diagnostic properties of different stress 
modalities are comparable and the choice between exercise-induced and 
pharmacological stress as well as between different pharmacological agents is 
influenced by other factors such as exercise capacity and available recourses [90]. 
However, one important advantage of dobutamine SE (DSE) is that it allows not only 
detection of ischemia, but also the evaluation of myocardial viability, thereby 
minimizing the number of tests needed for complete assessment.  
Set-up and protocol 
A typical contemporary set-up for DSE includes continuous ECG monitoring, an 
infusion pump for intravenous administration of dobutamine and a digital ultrasound-
image acquisition system with adequate software, including harmonic imaging for 
optimal endocardial border detection. Intravenous contrast agents for LV opacification 
may be used in cases of suboptimal image quality as well as for myocardial perfusion 
studies. Various dobutamine protocols are used but typically, infusion is started at a rate 
of 5 µg/kg/min, increased every 3 min to 10, 20, 30 and 40 µg/kg/min during 
continuous ECG monitoring. If target HR (≥ 85% of the predicted maximum HR) is not 
achieved, i.v. atropine may be added in 0.25 mg doses up to a maximum of 1–2 mg. 
Digital images are acquired at rest, during low dose infusion (10 µg/kg/min), at peak 
stress and during recovery. Termination criteria include detection of new wall motion 
abnormalities in > 1 segment, reaching target heart rate, onset of complex arrhythmias 
and intolerable symptoms.  
 
   15 
Image interpretation 
Images are preferably interpreted in a side-by-side manner, allowing direct comparison 
at different dose stages. Regional wall motion is analyzed by using the previously 
mentioned 16-segment model proposed by the ASE. An increase in wall motion score 
(i.e. decreased systolic wall thickening) in at least 2 adjacent segments during stress is 
considered diagnostic for inducible ischemia. Similarly, a decrease in wall motion score 
(i.e. increased systolic wall thickening) in at least 2 adjacent segments during low-dose 
dobutamine implies the presence of myocardial viability. When examining patients 
with LV dysfunction, different reaction patterns may be recognized during dobutamine 
stress. A biphasic response refers to increased contractility during low-dose dobutamine 
infusion, followed by deterioration at peak stress, indicating the presence of viable 
myocardium in combination with inducible ischemia (i.e. hibernation). Increased 
contractility at low dose may also be followed by further improvement at peak stress, 
typically seen in viable myocardium after revascularization (i.e. stunning). In non-
viable myocardium the response to dobutamine stress is either early deterioration at low 
dose or no change at all. In addition to the magnitude, analyzing the timing of wall 
motion may add diagnostic information, as contraction as well as relaxation is delayed 
during ischemia [94]. Attention should also be paid to LV dimensions and global 
systolic function. Although more frequently seen with exercise-induced stress, LV 
cavity dilatation and a decrease in LVEF during stress may indicate the presence of 
extensive CAD [95]. Visual wall motion analysis (WMA) is limited by interobserver 
variability [96]. Therefore, various parameters have been proposed for quantitative 
analysis during stress. Although still not completely incorporated into clinical practice, 
promising results have been seen in studies of parameters derived from myocardial 
velocity imaging, including peak systolic velocities and deformation indices such as 
strain and strain rate [97, 98].   
Detection of coronary artery disease 
As with other non-invasive tests, induction of ischemia during DSE depends on an 
optimal level of stress [99]. Thus, inability to achieve the target heart rate decreases 
sensitivity by way of false-negative results [100]. Other factors decreasing the 
probability of ischemia detection by DSE include the presence of LV hypertrophy and 
one-vessel disease [101]. Conversely, false-positive results, reducing specificity, are 
seen in patients with left bundle branch block and hypertension [102, 103]. Moreover, 
ischemic wall motion abnormalities may be induced during stress in patients with 
impaired coronary flow reserve due to microvascular dysfunction, even in the absence 
of significant epicardial CAD [104]. Analysis of pooled data from 17 studies in which 
the accuracy of stress echocardiography and myocardial perfusion imaging compared 
with an angiographic gold standard was examined showed sensitivity and specificity of 
80% and 86%, respectively, for detection of CAD by DSE [92] (Figure 9a). An equal 
level of accuracy for DSE and myocardial perfusion imaging was seen, although 
sensitivity was slightly lower and specificity higher for DSE. There is a trend towards 
improved accuracy of DSE in more recent studies, probably reflecting the enhanced 
image quality achieved by new applications such as harmonic imaging and intravenous 
contrast agents [105, 106].  
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Prediction of left ventricular functional recovery 
As previously discussed, assessment of myocardial viability has important clinical 
implications in patients with CAD. Based on its availability and low cost, DSE has 
been extensively used for the prediction of functional outcome in patients with 
ischemic LV dysfunction. In a meta-analysis of studies comparing DSE with perfusion 
imaging, DSE had sensitivity and specificity of 74% and 86%, respectively, for the 
prediction of functional outcome in post-MI patients (Fig. 9b). Corresponding values 
for the prediction of  functional recovery after revascularization in patients with chronic 
ischemic LV dysfunction were 74% and 80%, respectively [92] (Fig. 9c). Compared 
with perfusion imaging, DSE seems to be less sensitive but significantly more specific 
in the prediction of functional outcome. 
 
 a       b            c 
Safety 
The safety of DSE has been analyzed in large populations including previously healthy 
subjects with suspected CAD as well as in patients with recent MI [107, 108]. Minor 
side effects of dobutamine infusion, including non-cardiac chest pain, hypotension and 
nausea are common, occurring at a frequency of 4–11%, whereas severe, life-
threatening complications such as complex ventricular arrhythmias, MI and death are 
rare [109].  
DOPPLER TISSUE IMAGING 
Historical perspective and technical aspects 
Named after the Austrian physicist Christian Doppler (1803–1853), the Doppler effect 
describes the change in frequency of waves when the observer is moving relative to the 
source, quantified by the Doppler equation (Fig. 10). Doppler suggested this effect in 
his studies on stars of different colors published in 1843 [110]. In 1845, Buys Ballot, a 
Dutch professor of mathematics and physics, confirmed the Doppler effect as regards 
Figure 9. Sensitivity and specificity of dobutamine stress echocardiography and 
myocardial perfusion imaging for detection of coronary artery disease (a), prediction of left 
ventricular functional recovery after myocardial infarction (b) and revascularization for 
chronic ischemic left ventricular dysfunction (c). (Schinkel A. F. L. Eur Heart J 
2003;24:789-800) Reprinted with the permission of Oxford University Press.  
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sound waves by using a group of musicians playing a calibrated note on a train in the 
Utrecht–Amsterdam line. In modern technology and science, the Doppler effect has 
several practical applications including underwater acoustics, astronomical 
measurements and medical imaging.  
 
 
 
 
 
 
 
 
The history of Doppler ultrasonography for detection of heart motion dates back to the 
early 1960s [111]. In the following decade, it was postulated that Doppler-based 
quantification of myocardial velocities could be of value for assessment of regional 
myocardial function. However, clinical application of myocardial velocity imaging was 
not shown to be feasible until 30 years later [112]. Since then, improvement of 
ultrasonographic imaging and computer technology has enabled the development of 
modern systems with digital image acquisition for off-line analysis and frame rates 
allowing temporal resolution at a level required for analysis of tissue velocities as well 
as for timing of cardiac motion.  
In contrast to the low-amplitude and high-velocity signals obtained from blood flow, 
Doppler signals from myocardial tissue are characterized by high amplitude and low 
velocities; typically 10 times lower than those of normal blood flow in the heart. 
Myocardial velocities may be recorded either on line by pulsed wave spectral Doppler 
(Doppler tissue imaging, PW DTI) or off line by color coded Doppler 2D images (CC 
DTI), the former measuring peak velocities at a specific depth along a scanning line  
whereas the latter measures mean myocardial velocities in any segment within a 
complete scanning sector [113]. Velocities may be recorded either at the AV plane 
level (annular velocities) or at any myocardial segmental level between the base and 
apex. In the following, however, the term myocardial velocity will be exclusively used. 
Offline analysis of CC DTI recordings allows the calculation of additional parameters 
derived from myocardial velocities, including AV plane displacement (the time integral 
of velocity) and deformation indices as strain and strain rate, representing relative 
change in the length of a myocardial segment and its time rate. Careful adjustment of 
filter settings and gain as well as scale and sweep velocity is important for optimal 
signal quality. In modern ultrasound machines, presets are available for tissue velocity 
recordings.  
Recording and interpretation of myocardial velocity data 
Recording of myocardial velocities allows the analysis of regional changes in LV and 
RV contraction and relaxation as well as their temporal relationship to different phases 
of the cardiac cycle. Typically, PW DTI recordings include peak systolic as well as 
early and late diastolic velocities (Fig. 11). As analysis is performed on line, the region 
Figure 10. The Doppler equation for calculation of frequency shift. 
f, observed frequency; v, the velocity of waves in the medium; vs,  
the velocity of the source, relative to the medium; f0, actual 
frequency of waves from the source. 
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of interest has to be pre-specified and measurements in multiple segments require 
repeated recordings. In contrast, color-coded recordings allow off-line analysis and 
tracking of regional data from any point of interest within the scanned sector. As 
previously discussed, off-line analysis of CC DTI recordings also allows calculation of 
derived parameters such as strain and strain rate.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Validation 
Establishing the relationship to hemodynamic parameters as well as to results of non-
invasive gold standard methods has been important for the validation of myocardial 
velocities as markers of cardiac function. Several studies with simultaneous 
echocardiographic and invasive hemodynamic evaluation have demonstrated the 
correlation between myocardial systolic and diastolic velocities and invasive indices of 
LV systolic and diastolic function, such as the peak positive and negative first derivates 
of LV pressure (dP/dtmax) and the time constant of isovolumic relaxation (Tau, �) [114, 
115]. The ratio between the early diastolic velocity of mitral inflow and myocardial 
diastolic velocity assessed by DTI (E/E´) has been shown to correlate with LV filling 
pressures [116]. Doppler-derived myocardial velocities are considered to be relatively 
insensitive to loading conditions, although conflicting results from experimental and 
clinical studies have been reported [117-119]. Comparative studies have also confirmed 
the relationship between average systolic velocities and LVEF assessed by gold-
standard methods [120]. Similarly, RV systolic myocardial velocities correlate with 
invasive hemodynamic indices of RV systolic function as well as with RVEF in 
radionuclide angiography [121, 122]. In addition to validation, demonstration of 
feasibility and reproducibility as well as determination of reference values for healthy 
subjects have been important steps towards the introduction of myocardial velocity 
imaging techniques in clinical practice [123]. In the absence of heart disease, 
S 
E 
L
Figure 11. Myocardial systolic (S), early (E) and late (L) diastolic velocities 
recorded at the septal left-ventricular site, near the mitral annulus by means of 
pulsed-wave Doppler tissue imaging  in the apical 4-chamber view. 
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significant negative correlation are seen between age and LV velocities, more 
pronounced for diastolic than systolic velocities. In contrast, no such correlations are 
seen as regards the RV. Furthermore, myocardial velocities are higher in the basal 
compared with the apical parts of the ventricles. 
Clinical applications   
As a measure of global systolic function, the average of systolic myocardial velocities 
from multiple LV sites correlates with LVEF, and a cut-off value of > 7.5 cm/s has 
been shown to be an accurate predictor of normal LVEF [124]. Furthermore, reduced 
LV myocardial systolic velocity has been considered as a marker of systolic LV 
dysfunction in subclinical disease [125]. The peak systolic velocity in the RV free wall 
correlates relatively well with global RV systolic function and a value of < 11.5 cm/s 
predicts RVEF of < 45% with sensitivity and specificity of 90% and 85%, respectively. 
Currently, the use of myocardial diastolic velocities for evaluation of LV diastolic 
function is probably the most well established clinical application of DTI. As 
previously mentioned, there is a clear relationship between E/E´ and LV filling 
pressure. A value of > 15 identifies patients with elevated filling pressures, whereas a 
value of < 8 is highly predictive of a normal filling pressure [126]. Typically, early 
diastolic myocardial velocity is reduced at all stages of diastolic dysfunction and this is 
therefore useful for distinction between normal and pseudonormal filling patterns as 
well as to differentiate between restrictive cardiomyopathy and constrictive pericarditis 
[127]. Numerous studies have demonstrated the prognostic value of Doppler-derived 
myocardial velocities in different disease states including heart failure, hypertension 
and CAD [128-130]. Although not recommended in current guidelines, the temporal 
relationships between systolic velocity parameters at different LV sites have been used 
to assess intraventricular dyssynchrony and to predict the response to cardiac 
resynchronization therapy in heart failure patients [131].  
Finally, myocardial velocities and deformation indices have been used as 
quantitative markers of ischemia and viability during stress echocardiography. In a 
study including 242 patients undergoing DSE for suspected CAD, the diagnostic value 
of systolic myocardial velocities was equal to that of visual WMA [132]. Assessment 
of myocardial velocities during dobutamine stress is feasible, with relatively high 
reproducibility, especially for systolic velocities in basal myocardial segments [133]. In 
healthy subjects, peak systolic velocities in basal segments typically increase 100% at 
peak stress compared with 50–75% in patients with CAD. The best discriminators of 
disease, however, seem to be the absolute values of systolic velocities at peak stress 
[97]. Furthermore, deformation indices such as strain rate have been shown to add 
incremental diagnostic value to WMA during DSE for suspected CAD [134]. In 
patients with ischemic LV dysfunction, changes in systolic myocardial velocities 
during low-dose dobutamine infusion have been used for the assessment of myocardial 
viability and prediction of LV recovery after revascularization [135]. The use of strain 
rate imaging during DSE has been shown to add incremental value to WMA in the 
assessment of myocardial viability and prediction of LV functional recovery after 
revascularization [136].  
 
 20 
THE MYOCARDIAL PERFORMANCE INDEX 
In 1995 Tei et al. proposed a new index of combined systolic and diastolic LV function 
based on time intervals from Doppler measurements of mitral inflow and LV outflow 
(the Tei-index) [137]. The Tei-index is calculated by dividing the sum of the 
isovolumic contraction and relaxation time intervals by the ejection time (Fig. 12). The 
rationale for the use of such an index is that in many disease states systolic and diastolic 
dysfunction coexist. As a result, prolongation of the isovolumic intervals as well as 
shortening of the ejection time reduces the time for effective pumping. Thus, taking 
both systolic and diastolic aspects of ventricular function into account, the Tei-index 
could be a more sensitive measure of disease than parameters separately assessing 
systolic or diastolic function. In their first description of the Tei-index, the authors 
demonstrated its feasibility and reproducibility, established reference values for healthy 
subjects and showed that the index increased with disease severity in patients with 
dilated cardiomyopathy. In subsequent publications, the diagnostic and prognostic 
values of the Tei-index have been established in a variety of clinical settings including 
ischemic heart disease, heart failure and valvular heart disease [138-140]. Similarly, a 
RV Tei-index has been used as a marker of RV function in patients with pulmonary 
hypertension, MI and congenital heart disease [141-143]. Moreover, applied during 
DSE, the Tei-index, also named the myocardial performance index (MPI) has been 
used as a marker of inducible ischemia and contractile reserve [144, 145] as well as for 
prediction of prognosis after MI [146]. An alternative mode of calculating the MPI  
from time intervals derived by DTI has been proposed [147] (Fig 13). Values of MPI 
derived from DTI correlate with values of the conventionally measured Tei-index but 
are typically higher. Moreover, although conflicting results have been reported, MPI 
derived from DTI seems to be less sensitive to loading conditions than the 
conventionally measured Tei-index [148]. 
 
 
 
 
 
Figure 12. Calculation of the myocardial performance index (MPI) from Doppler 
recordings of mitral inflow and left ventricular outflow. MPI=(ICT + IRT) / ET = (a – 
b) / b. ET, ejection time; ICT, isovolumic contraction time; IRT, isovolumic relaxation 
time; LV, left ventricle. (Tekten T. Echocardiography 2003;20:503-10) Reprinted 
with the permission of John Wiley and sons. 
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Figure 13. Calculation of the myocardial performance index (MPI) from Doppler 
tissue imaging recordings. MPI = (a – b) / b.  
Am, diastolic velocity during atrial contraction; Em, early diastolic velocity; Sm, 
systolic velocity. (Tekten T. Echocardiography 2003;20:503-10) Reprinted with the 
permission of John Wiley and sons. 
 22 
AIMS OF THE THESIS 
The aims of this thesis was to evaluate the use of Doppler tissue imaging as a 
complement to conventional echocardiographic parameters at rest and during 
dobutamine stress in patients with acute ST-elevation myocardial infarction, and with 
specific focus on: 
 
 
• The use of RV systolic velocities for the detection of RV infarction and for the 
assessment of RV function over time. 
 
• Evaluation of myocardial velocities in patients with complete recovery of 
conventional echocardiographic parameters of LV function at late follow-up. 
 
• The application of MPI derived from DTI during DSE as a quantitative marker 
of inducible ischemia. 
 
• The value of MPI derived from DTI during DSE as a predictor of late recovery 
of LV systolic function. 
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PATIENTS AND METHODS 
Patients 
The study population consisted of 90 patients included in the Swedish Early Decision 
reperfusion Study (SWEDES) in which reperfusion treatment with thrombolysis was 
compared with primary PCI in patients with STEMI [149]. Patients were enrolled at 
Södersjukhuset, Stockholm, Sweden, between November 2001 and May 2003. 
Inclusion criteria were characteristic chest pain with a duration of a maximum of 6 h, 
the presence of ST-segment elevation of at least 1 mm in two contiguous leads and 
diagnostic serial changes in serum cardiac troponin T concentrations (≥0.2 µg/L). All 
patients received reperfusion therapy by means of thrombolysis (n=45) or primary PCI 
(n=45). Additional pharmacological treatment was introduced according to 
recommendations in present guidelines. A symptom-limited bicycle stress test was 
performed prior to discharge. 
Healthy subjects 
In Study II, 41 healthy subjects (27 male and 14 female, age 57 ± 13 years, 7 smokers) 
without a history of cardiovascular disease, diabetes mellitus or hypertension and with 
a normal resting ECG and echocardiogram served as controls. In Study I, a subgroup of 
31 healthy subjects was used, as the age distribution was slightly different compared 
with that in Study II.  
METHODS 
ECG 
Standard 12-lead electrocardiograms with the addition of the right precordial lead V4R 
were recorded at presentation and the day after admission. Electrocardiographic criteria 
for inclusion are defined above. Right ventricular infarction was defined as an ST-
segment elevation of ≥ 1 mm in lead V4R.  
Echocardiography 
Echocardiographic recordings were made using a Hewlett-Packard Sonos 5500 
(Andover, Mass, USA) phased-array system with DTI technology and a variable 
frequency transducer (2.0–4.0 MHz). Subjects were examined in the left lateral 
decubitus position at day 1 (within 24 hours after admission), 5–7 days and 6 months 
after admission. Images were stored digitally on magneto-optical discs for off-line 
measurements and were analyzed separately by a physician blinded to clinical data. 
Recordings and calculations of cardiac dimensions were made according to the 
recommendations of the American Society of Echocardiography (ASE) [81]. If image 
quality allowed adequate endocardial border detection, global LV systolic function 
expressed as EF was calculated by the biplane method of discs. Alternatively, EF was 
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assessed visually by two physicians and in case of disagreement, a consensus decision 
was made. Regional LV function was assessed in a 16-segment model as proposed by 
the ASE [81]. Parameters of LV diastolic function including the ratio between 
transmitral E-wave and A-wave velocities, mitral E-wave deceleration time, isovolumic 
relaxation time and pulmonary venous flow pattern were assessed using PW flow 
Doppler recordings of mitral inflow and LV outflow as well as of pulmonary venous 
flow. Right ventricular function was assessed by TAPSE in M-mode recordings of the 
RV lateral free wall. 
Dobutamine stress echocardiography 
Stress echocardiography was performed at day 5–7 after admission. During continuous 
12-lead ECG monitoring, dobutamine was infused at rates of 5, 10, 20, 30 and 40 
µg/kg/min. If the target HR (≥ 85% of the predicted maximum HR) was not achieved, 
iv atropine was added at 0.25 mg doses up to a maximum of 1 mg. Echocardiographic 
recordings including DTI were obtained at rest, during low-dose infusion (10 
µg/kg/min.) and peak stress. Images were stored digitally and analyzed separately.  
Wall motion analysis 
For interpretation of DSE results, digitally stored images were displayed in a side-by-
side manner allowing simultaneous assessment of recordings at different levels of 
stress. Using the 16-segment model, each segment was assigned a wall motion score (1 
= normokinesia, 2 = hypokinesia or 3 = akinesia or dyskinesia). Wall motion score 
index (WMSI) was calculated as the sum of wall motion scores divided by the number 
of segments assessed. Inducible ischemia was defined as worsening of wall motion in 
at least 2 adjacent segments during stress. In segments with normal wall motion at rest, 
an ischemic response was defined as a change to hypokinesia or akinesia/dyskinesia at 
peak stress. In segments with hypokinesia or akinesia/dyskinesia at rest, an ischemic 
response was defined as either an improvement at low dose with a subsequent 
worsening at peak stress (biphasic response) or a continued hypokinesia at low dose, 
followed by further worsening to akinesia/dyskinesia at peak stress [150]. Myocardial 
viability was defined as an improvement of wall motion between rest and low dose (i.e. 
a change from akinesia to hypo- or normokinesia, or a change from hypokinesia to 
normokinesia) in at least 2 adjacent segments [151]. 
Doppler tissue imaging 
Left and right ventricular longitudinal myocardial velocities were recorded using 
pulsed-wave DTI. For the LV, peak systolic, and early and late diastolic velocities were 
recorded from the septal, lateral, inferior and anterior sites near the mitral annulus in 
apical 2- and 4-chamber views. Similarly, for the RV, myocardial velocities were 
recorded from the lateral free wall near the tricuspid annulus in the apical 4 chamber 
view. The custom filter settings for DTI recordings were used with adjustment of the 
low pass filter (50Hz) and gain for optimal image quality. A 1.7 mm sample volume 
was used. All parameters were calculated as mean values of three consecutive cycles. 
In Study II, the mean myocardial velocity from the 4 LV sites was used as a measure of 
global systolic function. E/E’ was calculated by dividing the peak early diastolic 
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velocity of mitral inflow by the peak early diastolic myocardial velocity from the septal 
LV site. 
Myocardial performance index 
From DTI recordings at rest and during dobutamine stress, MPI was calculated as the 
sum of the time intervals corresponding to isovolumic contraction and relaxation 
divided by the interval corresponding to ejection time (Fig. 13).  
Coronary angiography 
Coronary angiography was performed within 24 hours after DSE. All angiograms were 
assessed visually and significant stenosis was defined as luminal narrowing of at least 
50% in two different projections. Patients with the culprit lesion located in the RCA 
were considered to have RV involvement if the occlusion was located proximal to the 
first RV branch. According to national guidelines at the present time, PCI was 
performed if ischemia was present in a preceding bicycle stress test. 
Statistical analysis 
Statistical analyses were performed using SPSS Statistical software versions 16 and 17 
(SPSS Inc., Chicago, Illinois, USA). Numerical values are expressed as means and one 
standard deviation. According to their distributions, comparisons of continuous 
variables between groups were made using Student’s unpaired t test or the Mann–
Whitney U test. Paired samples t tests were used for comparisons within groups. 
Categorical variables were analyzed using the chi-square test or Fisher’s exact test. 
Analysis of variance (ANOVA) with Bonferroni correction was used for comparisons 
of more than two groups. A p-value of < 0.05 was considered statistically significant. In 
Studies I, III and IV, receiver operating characteristics (ROC) curves were used to 
determine cut-off values for RV systolic velocity and MPI. In order to assess inter- and 
intra-observer variability, a second analysis in 20 randomly selected patients was made 
1 month later by the first, as well as a second reviewer. In Study I, variability was 
calculated as the absolute difference between observations divided by their mean. In 
Studies III and IV, variability of WMA was expressed as the level of agreement 
(Kappa) in the classification of results as positive or negative for ischemia and viability. 
For MPI, variability was assessed using Cronbach’s alpha and the Bland–Altman 
method [152]. In Study IV, multivariable logistic regression analysis was used to assess 
the value of MPI as a predictor of LV functional recovery. 
Ethics 
This study was approved by the Local Ethics Committee of the Karolinska Institute in 
Stockholm. All patients gave their informed consent to participate.  
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Day 5-7 
Echo 
DSE 
Angio 
6 months 
Echo 
Day 0-1 
ECG 
Echo 
Study II 
n=68
Study I 
n=71
Study III 
n=77
Study IV 
n=76
RESULTS 
Study flow-chart 
Time courses, methods and numbers of patients in Studies I–IV are presented bellow. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Clinical characteristics and outcome  
Baseline characteristics of the 90 patients included in the study are presented in Table 
1. One patient was excluded after withdrawal of consent prior to DSE and control 
angiography. One patient with ischemic stroke on day 2 after admission was also 
excluded. There were 3 in-hospital deaths, of which 2 occurred during the first 24 hours 
and 1 at day 3 after admission. One patient died and 3 patients were admitted because 
of MI during the first 6 months after discharge.  
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Table 1. Baseline clinical characteristics of MI patients 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Right ventricular infarction (Study I) 
Electrocardiographic signs of RV involvement (ST-elevation in V4R) were present in 
17 (24%) of the patients included in Study I. In 15 of these, the culprit coronary lesion 
was located in the RCA with 13 (87%) proximal to the first RV branch. In patients 
without ST-elevation in V4R the culprit lesion was in the LAD in 24 (44%), the LCx in 
5 (9%) and the RCA in 25 patients (46%). Of the latter, 3 patients (12%) had an 
occlusion proximal to the first RV branch. In 3 patients persistent ST-elevation in V4R 
was seen the day after admission. Clinical signs of RV infarction including hypotension 
and jugular venous distention were seen in 4 patients (24%), of whom all had a 
proximal RCA occlusion. Analysis of RV myocardial systolic velocity and TAPSE 
during the first 24 hours after admission identified patients with RV infarction with 
sensitivity of 89% and 82% and specificity of 71% and 76%, respectively (cut-off 
values 13 cm/s for RV systolic velocity and 20 mm for TAPSE). In patients with RV 
infarction, a significant increase in RV systolic velocity and TAPSE was seen between 
day 1 and the 6-month follow-up. However, RV systolic velocity at follow-up was still 
significantly lower than in patients without RV infarction (12.3 ± 2.3 vs. 14.2 ± 2.4 
cm/s, p < 0.01). 
Coronary angiography and revascularization procedures 
As a result of incomplete reperfusion or recurrent ischemia, urgent coronary 
angiography with revascularization was performed during the first 48 hours after 
admission in 14 of the 45 patients initially treated with thrombolysis. No angiographic 
follow-up at day 5–7 was carried out in these patients. Seventy-two patients underwent 
control angiography at day 5–7. Of these, 17 were subject to revascularization by way 
of PCI (10 patients initially treated with thrombolysis and 7 patients initially treated 
with primary PCI). Between discharge and 6 months’ follow-up, 13 patients underwent 
revascularization procedures (10 PCI, 3 CABG). Angiographic data from primary PCI, 
urgent secondary PCI or control angiography were available in 89 patients. Prior to 
n = 90 
Age (yr) 
Sex (M/F) 
Smokers 
Diabetes 
Hypertension 
History of MI 
TL/PCI 
Ant/Inf MI 
ST-elevation V4R 
Trop T (µg/L) 
65±13 
64 (71%) / 26 (29%) 
21 (23%) 
18 (20%) 
25 (28%) 
13 (14%) 
45 / 45 
32 (36%) / 58 (64%) 
23 (26%) 
6.5 ± 6.1 
MI, myocardial infarction; TL, thrombolysis; PCI, percutaneous coronary 
intervention; Ant, anterior; Inf, inferior; Trop. T, Troponin T. 
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revascularization procedures, 41 patients (46%) had 1-vessel disease, 31 (35%) had 2-
vessel disease and 18 (20%) had 3-vessel disease.   
Detection of coronary artery disease (Study III) 
Dobutamine stress echocardiography 
Dobutamine stress echocardiography was performed in 77 patients (53 men and 24 
women, aged 64±13 years). Side effects resulting in termination of dobutamine 
infusion included frequent premature ventricular contractions (1 patient) and 
hypotension (2 patients). Blood pressure increased marginally during dobutamine 
infusion (136 ± 22 / 81 ± 14 mmHg at rest to 145 ± 19 / 83 ± 13 mmHg at peak stress). 
Target HR was achieved in 34 patients (mean 89 ± 6% of the age-predicted maximum 
HR), whereas in the remaining 44 patients, HR did not reach target levels (mean 76 ± 
9% of the age-predicted maximum HR).  
 
Wall motion analysis 
Of 1232 segments, 1164 were analyzed at rest, 1158 at low dose and 1148 at peak 
stress. An ischemic response was observed in 33 patients (43%). Sensitivity and 
specificity of WMA for the diagnosis of LAD, LCx and RCA disease were 64% and 
87%, 53% and 84%, and 60% and 81%, respectively.  
 
Myocardial performance index during dobutamine stress 
From recordings at the 4 LV sites in 77 patients, 308 MPI values were obtained, each 
considered to be a measure of regional LV function. Changes in MPI during 
dobutamine stress and the relationship to the presence of stenosis in the supplying 
coronary artery are illustrated in Fig. 14.  
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At rest and low dose, no significant differences were seen between the groups. At peak 
stress, however, MPI values were significantly higher at LV sites supplied by stenosed 
vessels. The relative change in MPI between rest and peak stress in regions supplied by 
stenosed and non-stenosed vessels is presented in Fig.15. From analysis of ROC curves 
it was evident that the relative change in MPI between rest and peak stress was a better 
discriminator of CAD compared with absolute values of MPI at peak stress (area under 
the curve 0.82, 95% CI 0.77–0.87, p < 0.001 for relative change and 0.71, 95% CI 
0.65–0.77, p < 0.001 for absolute values at peak stress). A cut-off value of a 15% 
increase in MPI identified stenosis with sensitivity and specificity of 59% and 80% for 
the LCx and 85% and 72% for the RCA. For the LAD, corresponding values were 87% 
and 80% when the anterior LV site was used and 67% and 86% for the septal site.    
 
 
 
 
 
Figure 14. MPI at rest and during dobutamine stress in regions supplied by stenosed 
and non-stenosed vessels. 
 30 
 
 
 
 
Prediction of LV functional recovery (Study IV) 
 
Wall motion analysis 
Improvement of wall motion in the infarct region during low-dose DSE was observed 
in 42 of 76 patients (55%). Sensitivity, specificity and negative and positive predictive 
values for the prediction of LV regional wall motion recovery were 82%, 84%, 76% 
and 88%, respectively.  
 
Myocardial performance index 
Anterior and inferior infarct regions were identified on the basis of the location of wall 
motion abnormalities at rest. Changes in MPI in infarct- and remote regions during 
low-dose DSE are presented in Fig. 16.  
 
Figure 15. Relative change in MPI between rest and peak stress in regions supplied by 
stenosed and non-stenosed vessels. 
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Decreasing MPI values during low-dose dobutamine infusion were observed in patients 
with subsequent recovery of wall motion. Conversely, an increase in MPI during DSE 
was seen in patients without functional recovery. Fig. 17 displays relative changes in 
MPI between rest and low-dose dobutamine infusion in patients with and without 
functional recovery. Analysis of the ROC curve showed that with a cut-off value of 0% 
and a specificity level of 84%, changes in MPI during low-dose DSE predict LV 
functional recovery with sensitivity and negative and positive predictive values of 87%, 
81% and 89%, respectively (AUC 0.86, 95% CI 0.77–0.95, p < 0.001). Changes in MPI 
values paralleled changes in wall motion over time. Thus, at 6 months’ follow-up, MPI 
values in patients with recovery of LV function were no longer significantly different 
from those in non-infarct regions. In patients without recovery of wall motion, MPI 
values remained at baseline levels, significantly higher than those of non-infarct 
regions. 
 
 
 
 
 
 
 
Figure 16. MPI at rest, during low-dose dobutamine and at 6 months’ follow-up in 
infarct regions with and without subsequent functional recovery as well as in non-
infarct regions. 
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Temporal changes in LV function (Studies II and IV) 
Study II 
At baseline (day 5–7), LV systolic function in patients with subsequent normalization 
of wall motion was significantly better compared with patients in whom wall motion 
abnormalities persisted. This was evident for all measures of LV systolic function, i.e. 
LVEF, WMSI and mean systolic myocardial velocity (S mean). Regarding LV diastolic 
function, however, conventional echocardiographic parameters did not differ 
significantly between the groups, whereas mean early diastolic myocardial velocity (E 
mean) was significantly higher and E/E’ significantly lower in patients with complete 
recovery of wall motion. 
Table 2 displays the temporal changes in different parameters of LV function 
between baseline and follow-up (also including baseline DTI parameters not published 
in Study II). Although still reduced after 6 months, a small but significant increase in 
LVEF was seen in patients with persistent wall motion abnormalities (45 ± 7.0% to 48 
± 8.2%, p < 0.01). Mean systolic myocardial velocities increased significantly in both 
groups, but the difference between groups was still evident at follow-up (7.1 ± 1.4 cm/s 
for patients with persistent wall motion abnormalities and 8.3 ± 1.3 cm/s for patients 
with complete recovery of wall motion, p < 0.01). With the exception of a significant 
increase in E-deceleration time in patients with persistent wall motion abnormalities, 
conventional parameters of LV diastolic function remained unchanged over time. A 
significant decrease in E/E’ was seen in both groups whereas early diastolic myocardial 
velocity increased significantly only in patients with complete recovery of wall motion 
(8.6 ± 2.4 cm/s to 9.3 ± 1.3 cm/s, p < 0.01).  
Figure 17. Relative change in MPI during low-dose dobutamine infusion in infarct 
regions with and without subsequent functional recovery
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At follow-up, systolic as well as diastolic myocardial velocities were significantly 
lower and E/E’ was significantly higher in patients with complete recovery of wall 
motion compared with healthy subjects. 
 
Table 2. Temporal changes in LV function (Study II) 
 Persistent wall motion 
abnormalities  
n=49 
Complete recovery of wall 
motion  
n=19 
 Day 5–7  6 months Day 5–7 6 months 
Systolic function 
 LVEF (%) 
 WMSI 
 S mean (cm/s) 
 
Diastolic function 
 E/A ratio 
 E-dec time (ms) 
 IVRT (ms) 
 E mean (cm/s) 
 L mean (cm/s) 
 E/E’ 
 
45 ± 7.0 
1.6 ± 0.4 
6.5 ± 1.2† 
 
 
1.1 ± 0.6 
206 ± 56 
93 ± 34 
7.2 ± 1.8†† 
8.8 ± 2.3†† 
11 ± 4.9† 
 
48 ± 8.2** 
1.5 ± 0.4 
7.1 ± 1.4** 
 
 
1.0 ± 0.5 
262 ± 66* 
102 ± 24 
7.4 ± 2.0 
8.6 ± 2.1 
8.3 ± 2.8** 
 
56 ± 5.0 
1.2 ± 0.2 
7.6 ± 1.2 
 
 
1.1 ± 0.3  
215 ± 36 
96 ± 17 
8.6 ± 2.4 
9.6 ± 1.7 
9.1 ± 2.7 
 
57 ± 4.4 
1.0* 
8.3 ± 1.3** 
 
 
1.1 ± 0.26 
218 ± 42 
91 ± 17 
9.3 ± 1.3** 
10.4 ± 2.4 
6.5 ± 2.3** 
S mean, mean systolic myocardial velocity from 4 LV sites; E mean, mean early diastolic myocardial 
velocity from 4 LV sites; L mean, mean late diastolic myocardial velocity from 4 LV sites 
* p < 0.001 compared with day 5–7 
**p < 0.01 compared with day 5–7 
† p < 0.01 compared with patients with complete recovery of wall motion 
†† p < 0.05 compared with patients with complete recovery of wall motion 
 p-values for between-group comparisons are only presented for unpublished data 
 
 
Study IV 
Parameters of LV systolic and diastolic function (including myocardial velocity data 
not included in Study IV) at baseline and follow-up are presented in Table 3. Similar to 
findings in Study II, baseline global LV systolic function was better in patients with 
subsequent functional recovery (LVEF 49 ± 7.2% vs 44 ± 7.8 for patients without 
functional recovery, p < 0.05).  However, this was not reflected by differences in 
regional systolic dysfunction expressed as peak systolic myocardial velocity (S peak) at 
the LV infarct site or by differences in WMSI. Conventional parameters of diastolic 
function were equal in the two groups at baseline, whereas peak early diastolic 
myocardial velocity (E peak) at the LV infarct site was significantly higher and E/E’ 
significantly lower for patients with recovery of LV function (8.0 ± 2.2 cm/s vs. 6.5 ± 
2.2 cm/s, p < 0.01 for E peak and 8.6 ± 2.6 vs. 11 ± 5.3, p < 0.05 for E/E’). In patients 
with recovery of LV function, significant changes over time were seen for all systolic 
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as well as DTI-based diastolic parameters of LV function. In contrast, no such changes 
were observed in patients without functional recovery.    
 
 
 
Table 3. Temporal changes in LV function (Study IV) 
 MI 
No recovery of LV function 
(n=31) 
MI  
Recovery of LV function 
(n=45) 
 Day 5–7  6 months Day 5–7 6 months 
Systolic function 
 LVEF (%) 
 WMSI 
 S peak (cm/s) 
 
Diastolic function 
 E/A ratio 
 E-dec time (ms) 
 IVRT (ms) 
 E peak (cm/s) 
 L peak (cm/s) 
 E/E’ 
 
MPI 
 
44 ± 7.8 
1.5 ± 0.4 
7.0 ± 1.4 
 
 
0.9 ± 0.4 
216 ± 63 
97 ± 31 
6.5 ± 2.2† 
8.9 ± 2.2 
11 ± 5.3†† 
 
0.81 ± 0.27 
 
45 ± 9.7 
1.5 ± 0.4 
6.7 ± 1.5† 
 
 
1.0 ± 0.4 
258 ± 55* 
103 ± 20 
6.5 ± 2.1† 
8.3 ± 1.9† 
12 ± 6.1† 
 
0.86 ± 0.25† 
 
49 ± 7.2 
1.4 ± 0.3 
7.5 ± 1.5 
 
 
1.2 ± 0.6  
224 ± 49 
94 ± 16 
8.0 ± 2.2 
9.0 ± 1.7 
8.6 ± 2.6 
 
0.75 ± 0.22 
 
54 ± 5.8* 
1.2 ± 0.3* 
8.1 ± 1.6** 
 
 
1.1 ± 0.5 
233 ± 53 
95 ± 20 
8.8 ± 1.9** 
9.7 ± 2.1 
7.3 ± 2.2*** 
 
0.58 ± 0.11* 
S peak, peak systolic myocardial velocity at LV infarct site ; E peak, peak early diastolic myocardial 
velocity at LV infarct site ; L peak, peak late diastolic myocardial velocity at LV infarct site.  
* p < 0.001 compared with day 5–7 
** p < 0.01 compared with day 5–7 
*** p < 0.05 compared with day 5–7 
† p < 0.01 compared with patients with recovery of LV function 
† † p < 0.05 compared with patients with recovery of LV function 
p-values for between-group comparisons are only presented for unpublished data 
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GENERAL DISCUSSION 
Right ventricular infarction (Study I) 
Early diagnosis of RV involvement in patients with STEMI is important. Although not 
always present, hemodynamic impairment may appear suddenly, requiring specific 
treatment considerations. The ischemic right ventricle is less compliant and therefore 
depends on adequate preload and heart rate to maintain a normal stroke volume and 
cardiac output. Hence, pharmacological agents affecting these parameters must be used 
with caution and plasma volume expansion as well as temporary pacing are often 
indicated. Moreover, attention should be paid to the coronary anatomy as the patency 
status of RV branches from the RCA may affect long-term prognosis in patients with 
RV infarction [69]. Among different methods for diagnosis of RV infarction, ECG 
remains the most simple and available, allowing very early recognition of RV 
involvement, even in the pre-hospital phase. The presence of ST-elevation in right 
precordial leads, especially V4R, has been extensively used for identification of RV 
infarction and the correlation with echocardiographic, scintigraphic and invasive 
hemodynamic evidence of RV involvement has been established [153-155]. These 
ECG changes, however, are transient and sometimes disappear within the first few 
hours of onset [67], as also evident in our study, where resolution of ST changes in 
V4R was observed within 24 hours in 82% of the patients. Gold standard methods for 
evaluation of RV function such as cardiac magnetic resonance imaging and invasive 
hemodynamic measurements are time-consuming and usually not suitable for early 
assessment. In contrast, echocardiography has evolved as a simple tool for early 
evaluation of patients with acute MI. Right ventricular dysfunction may be appreciated 
visually by the presence of wall motion abnormalities, or by quantitative methods such 
as fractional area change [85]. In an acute setting, however, suboptimal imaging 
conditions may limit the feasibility of methods requiring complete endocardial border 
detection. Therefore, easily assessable surrogate parameters of RV function such as 
peak systolic myocardial velocity and TAPSE are attractive options for 
echocardiographic evaluation of patients with suspected RV infarction. Indeed, the 
results of previous studies show not only that RV systolic velocity and TAPSE 
correlate well with RVEF, but also that they may identify patients with RV 
involvement in the acute phase of  MI [68, 122, 156, 157]. In our study, RV free wall 
velocity of < 13 cm/s identified the vast majority of patients initially presenting with 
ST-elevation in V4R. However, the application of this cut-off value resulted in a 
relatively low specificity of 71% which probably is an overestimation of the true 
specificity because of selection bias from exclusion of patients with well-known causes 
of reduced RV myocardial velocities. Nevertheless, in this context, false-positive 
results have acceptable clinical consequences, mainly consisting of increased attention 
to clinical signs of hemodynamic impairment. Furthermore, it cannot be ruled out that 
some of the false-positive results actually reflected persistent RV dysfunction following 
transient RV ischemia.  
In our study, use of an angiographic definition would have resulted in identification 
of fewer RV infarctions compared with an ECG-based definition (13 and 17 patients, 
respectively). It must be pointed out though, that the presence of ST-elevation in V4R 
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reflects transmurality of RV ischemia, not necessarily implicating extensive myocardial 
necrosis. Distribution of the coronary vessels supplying the RV is multi-territorial, with 
contribution from the right as well as the left coronary arteries. Branches arising from 
the LAD mainly supply the apical part, representing a limited proportion of the entire 
RV. In our study, patients in whom RV infarction was associated with an occlusion in 
the LAD or distal RCA did not develop hemodynamic impairment. In contrast, clinical 
manifestations of RV infarction were relatively common in patients with proximal 
RCA occlusions. Hemodynamic impairment may be even more severe if the proximal 
occlusion affects right atrial branches thereby compromising perfusion of the right 
atrium, and resulting in loss of atrial contribution to RV diastolic filling [158]. Thus, 
early angiographic assessment allows identification of patients at risk of hemodynamic 
impairment. However, in the absence of invasive facilities, echocardiographic 
assessment remains an important diagnostic tool in patients with RV infarction. This 
also holds true for serial assessment and follow-up of RV function over time. Right 
ventricular function typically exhibits relatively rapid recovery after infarction, even in 
the absence of reperfusion of the culprit vessel [159, 160]. Mechanisms protecting the 
RV from extensive permanent ischemic dysfunction include abundant collaterals, a 
favorable balance between oxygen supply and demand and a coronary flow profile 
allowing diastolic as well as systolic perfusion of the RV myocardium [63, 161, 162].  
In contrast, the results of our study suggest that residual RV myocardial damage 
may persist even at late follow-up. Although increased over time, systolic RV 
myocardial velocities in patients with RV infarction remained reduced compared with 
those in patients without RV infarction. These findings have been confirmed in a recent 
study in which peak systolic velocity and RV MPI were used for evaluation of RV 
function in the early and late phase after a first inferior MI [163]. The possible 
prognostic implications of these persistent abnormalities, however, were not addressed 
in either of the studies.  
Detection of coronary artery disease (Study III) 
The impact of ischemia on different aspects of LV function is classically described by 
the sequential chain of events in the ischemic cascade (Fig. 5). Initial abnormalities in 
coronary blood flow are followed by regional diastolic dysfunction, systolic wall 
motion abnormalities, ischemic ST-depression and finally symptoms. The temporal 
relationship between these events may contribute to the understanding of differences in 
diagnostic properties of various stress tests. It is evident that observation of perfusion 
abnormalities would be the most sensitive tool for detection of CAD. Indeed, most 
comparative studies show a slightly higher sensitivity for myocardial perfusion imaging 
vs. DSE with WMA  [92]. The additive value of perfusion in regard to function is 
further illustrated by the increase in sensitivity in the detection of CAD seen with 
myocardial contrast echocardiography compared with WMA alone [164].  
 
Quantitative markers of ischemia – diastolic indices 
The ischemic cascade also forms a rationale for the use of diastolic indices as markers 
of ischemia during stress. Experimental as well as clinical studies have consistently 
shown that regional diastolic dysfunction occurs within seconds of ischemia induction, 
followed by regional systolic wall motion abnormalities and global LV dysfunction 
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[31, 165]. A linear relationship has been established between the extent of ischemia and 
regional diastolic myocardial velocities [166]. In clinical practice, conventional 
parameters of diastolic function have been difficult to apply in stress echocardiography 
because of the load-dependency of mitral inflow. In contrast, DTI-derived parameters 
such as diastolic myocardial velocity and E/E’ seem to be sensitive to stress-induced 
ischemia [167, 168], although specificity is negatively influenced by the presence of 
other causes of diastolic dysfunction such as LV hypertrophy and diabetes mellitus. 
Interestingly, the results of a recent study also demonstrate a link between stress-induced 
ischemia and reduced LV diastolic untwisting during isovolumic relaxation [169].  
 
Quantitative markers of ischemia – systolic indices  
Moving upwards along the temporal axis of the ischemic cascade, a further shift of the 
balance between oxygen supply and demand towards ischemia results in the occurrence 
of regional systolic wall motion abnormalities, being the focus of WMA in stress 
echocardiography. However, although widely used for detection of myocardial 
ischemia, stress echocardiography is limited by the subjective nature of WMA [96, 
170]. Therefore, great interest has been directed towards potential quantitative markers 
of stress-induced ischemia. In addition to the diastolic indices discussed above, changes 
in the displacement of the atrioventricular plane during exercise and myocardial 
systolic velocities assessed by DTI during dobutamine stress have been shown to 
identify patients with CAD [132, 171]. Moreover, myocardial systolic velocities during 
DSE seem to be superior to WMA for the detection of CAD in patients with left bundle 
branch block [172]. The main limitation of using myocardial velocities during stress for 
the identification of ischemic segments is the interaction between different myocardial 
regions, or tethering of segments. Thus, myocardial velocities in one segment may be 
affected by stress-induced hyperkinesia in adjacent segments as well as by overall 
cardiac motion. This phenomenon was illustrated in a previous study, were myocardial 
systolic velocities during dobutamine stress failed to localize regional ischemia as 
assessed by myocardial perfusion imaging, but accurately identified patients with any 
ischemic response [173]. The problem with tethering segments may be overcome by 
the use of myocardial deformation indices such as strain and strain-rate, both proposed 
as more specifically assessing regional myocardial function [174, 175]. Indeed, the use 
of strain-rate has been shown to add incremental diagnostic value to conventional wall 
motion analysis in patients undergoing dobutamine stress echocardiography because of 
suspected CAD [134]. Deformation imaging is limited mainly by poor reproducibility 
and dependency on recording angle and image quality [98].  
 
Myocardial performance index 
The temporal resolution of myocardial velocity imaging techniques allows analysis of 
the impact of ischemia on the velocity profile over the entire cardiac cycle. In the 
normal myocardium, early systolic shortening is seen as a positive, high amplitude 
velocity with short duration, corresponding to isovolumic contraction. Induction of 
ischemia results in a gradual decrease of amplitude, ultimately reversed to a large 
negative isovolumic contraction velocity in the presence of severe ischemia [176]. 
Similarly, with increasing ischemia, myocardial shortening continues after aortic valve 
closure and into the isovolumic relaxation phase, a phenomenon referred to as 
postsystolic shortening [177]. These findings are consistent with the effects of ischemia 
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on isovolumic time intervals observed during flow Doppler recordings [178, 179], 
forming the rationale of using MPI for detection of ischemia. In patients undergoing 
DSE, Ling et al. showed that among different time intervals and indices from flow 
Doppler recordings, MPI was the best discriminator for identification of an ischemic 
response [144]. First described by Tei et al, MPI was calculated from conventional 
systolic and diastolic Doppler time intervals of aortic and mitral flow, and therefore 
considered to be a marker of global rather than regional LV function [137]. The 
application of myocardial velocity imaging techniques such as DTI offers an alternative 
way of calculating MPI [147]. It should be noted, however, that the different 
approaches using flow-derived or DTI-derived MPI do not yield identical results. 
Typically, DTI-derived MPI requires higher cut-off values for distinction between 
normal and dysfunctional myocardium. Nevertheless, both assess the relationship 
between isovolumic and ejection phases, and when DTI-derived MPI is averaged from 
different LV sites, they have been shown to correlate in healthy subjects as well as in 
patients with LV dysfunction [180, 181].  
In the present study, MPI was separately analyzed at different LV sites. We found 
that changes in MPI during dobutamine stress may identify myocardial regions 
supplied by stenosed coronary vessels. Thus, MPI was used for detection of CAD at a 
regional vessel territory level as opposed to the analysis of individual myocardial 
segments used in WMA. Theoretically, temporal resolution of the myocardial velocity 
profiles obtained during DTI would also allow assessment of MPI in a segment-based 
manner. However, the typical gradual changes in myocardial velocities seen from basal 
to apical segments of the LV would be a potential source of error, especially in the 
apical region, where little longitudinal shortening occurs. Different imaging angles at 
different levels would further complicate the analysis. Analysis of MPI at basal LV 
sites resulted in fairly accurate detection of stenoses in major coronary vessels. The 
main limitation of this approach is the individual variation in coronary anatomy. While 
the LAD most often supplies the anteroseptal and anterior parts of the LV, the 
perfusion territories of the LCx and the RCA exhibit substantial variation between 
dominant and codominant variants [26]. Moreover, we did not analyze MPI at the true 
posterior LV site, possibly resulting in failure to detect stenoses in major posterolateral 
branches. These facts may help to explain the lower sensitivity observed as regards 
detection of LCx disease.  
Although not a pre-specified objective of the study, we found that despite a 
suboptimal level of stress in a majority of the patients, regional changes in MPI 
identified the presence of CAD with reasonable sensitivity. In contrast, sensitivity of 
conventional assessment with WMA was far below the level usually seen for DSE. 
This discrepancy agrees well with the fact that WMA is exclusively based on 
assessment of changes during systole, whereas MPI reflects both systolic and diastolic 
changes in LV function, the latter appearing at an earlier stage in the ischemic cascade. 
Thus, analysis of MPI during stress seems to be particularly useful when target HR is 
not achieved, constituting a potential clinical application in patients with ongoing beta-
blocker treatment. 
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Myocardial viability and recovery of LV function (Studies II and IV) 
Assessment of myocardial viability and prediction of LV functional recovery have 
important clinical implications in patients with ischemic LV dysfunction. The presence 
or absence of viability may affect decision-making prior to revascularization and the 
probability of persisting LV dysfunction may influence timing of cardiac 
resynchronization therapy and the use of implantable cardioverter defibrillators. In the 
present study, we evaluated the use of MPI during DSE for prediction of LV functional 
recovery in patients presenting with a STEMI.  
The timing of follow-up was based on a balance between the expected delay in LV 
recovery and the risk of new ischemic events. As previously discussed, induction of 
ischemia by limitation of coronary blood flow immediately results in impaired LV 
function followed by gradual recovery after restoration of myocardial perfusion. The 
time course of this improvement depends on several factors, including the severity and 
duration of ischemia as well as the presence of residual myocardial hypoperfusion, 
ranging from days up to several months. The width of this time span probably reflects 
the composition of metabolic and structural abnormalities seen in ischemic LV 
dysfunction. Brief episodes of ischemia mainly result in metabolic changes involving 
calcium turnover and oxygen free radicals as in myocardial stunning, whereas chronic 
hypoperfusion, typical of hibernating myocardium, is associated with cellular structural 
changes such as accumulation of glycogen, myofibril loss and fibrosis [53, 54, 182]. 
Moreover, following MI, coexistence of stunned, hibernating and necrotic myocardium 
can be expected, further complicating the prediction of functional recovery.  
 
Assessment of viability 
Apart from being determinants of delay in LV recovery, the metabolic and structural 
abnormalities seen in necrotic and viable but dysfunctional myocardium may help to 
explain some properties of different methods for assessment of viability. Necrotic 
myocardium is characterized by microvascular damage and loss of myocyte membrane 
integrity (i.e. metabolic activity). In contrast, viable myocardium typically exhibits 
intact membrane integrity and a variable degree of perfusion abnormalities. Therefore, 
imaging modalities incorporating both perfusion and metabolism are ideal methods for 
assessment of myocardial viability. Positron emission tomography (PET) with tracing 
of 18F-fluorodeoxyglucose (FDG) is considered as the gold standard for assessment of 
viability and has been shown to be useful in patient selection prior to revascularization 
[183]. The use of PET for assessment of viability in clinical practice, however, is 
limited by low availability. More available and widely used, myocardial perfusion 
imaging with single-photon computed tomography (SPECT) has been shown to detect 
viable myocardium accurately and to predict LV recovery in patients with ischemic LV 
dysfunction [184, 185]. However, in the acute phase after MI, SPECT seems less 
accurate in predicting recovery of LV function [186]. The evolution of cardiac 
magnetic resonance imaging (MRI) has offered a new modality for viability assessment 
and the addition of gadolinium contrast agents allows assessment of infarct 
transmurality, being highly predictive of LV functional recovery [187, 188]. Although 
increasing, the availability of MRI is still limited and the need for simple methods with 
high availability in daily practice is apparent. Fulfilling these criteria, DSE has been 
frequently used for assessment of myocardial viability and several studies have 
established the value of DSE for prediction of LV functional recovery [92]. Assessment 
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of viability by DSE is based on detection of contractile reserve. Thus, metabolic and 
other structural changes are not taken into account, probably at least partly explaining 
the lower sensitivity for prediction of functional recovery seen with DSE when 
compared with SPECT in chronic ischemic LV dysfunction. The introduction of 
myocardial contrast agents allowed simultaneous assessment of contractile reserve and 
microvascular integrity, thereby increasing sensitivity for prediction of LV functional 
recovery [189]. Moreover, analysis of systolic velocity indices at rest and during 
dobutamine stress has also been proved to add diagnostic information in the assessment 
of myocardial viability [190, 191]. Data on diastolic parameters, however, are limited.  
 
Viability, diastolic function and myocardial performance index 
Left-ventricular relaxation is partly an active, energy-requiring process and therefore it 
is not surprising that diastolic function is independently associated with the presence of 
myocardial viability [192, 193]. Furthermore, in viable myocardium, diastolic function 
may improve during low-dose dobutamine infusion [194]. Results from a recent 
experimental study showed that analysis of diastolic strain-rate during low-dose DSE 
accurately distinguished transmural from nontransmural myocardial infarction [195]. 
Given these facts, incorporating diastolic parameters of LV function in the assessment 
of myocardial viability seems appealing. We tested this concept using a combined 
index of systolic and diastolic function and showed that changes in MPI derived from 
DTI during low-dose DSE seem to exhibit a specific pattern allowing prediction of 
functional recovery in patients with LV dysfunction following MI. These findings are 
consistent with the results of previous studies in which flow Doppler-derived MPI 
during DSE in patients with recent MI has been evaluated [145, 196]. In healthy 
controls as well as in patients with contractile reserve, a decrease in MPI resulting from 
a shortening of isovolumic time intervals relative to ejection time was seen during low-
dose dobutamine infusion. Conversely, an increase in MPI resulting from failure to 
shorten isovolumic intervals was seen in patients without contractile reserve. 
Furthermore, an increase in MPI during low-dose DSE was an independent predictor of 
subsequent LV dilatation and adverse events. These changes in MPI reflect the 
complex response to inotropic stimulation seen in normal and dysfunctional 
myocardium. By decreasing the duration of isovolumic intervals, a greater part of the 
cardiac cycle may be used for diastolic filling, thereby enabling an increase in stroke 
volume. In patients with ischemic LV dysfunction, limitation of the ability to increase 
stroke volume during dobutamine stimulation is associated with failure in shortening of 
isovolumic time intervals [197]. This link between impaired relaxation and an 
abnormal response to inotropic stimulation further emphasizes the important role of 
diastolic function in myocardial viability. Indeed, we found that baseline early diastolic 
myocardial velocities were higher and E/E’ was lower in patients with recovery of LV 
function.  
A positive outcome in our study was defined as recovery of regional systolic wall 
motion in the infarct region, and although significant improvement of LVEF was seen 
in patients with recovery of regional LV function, the predictive value of changes in 
MPI during DSE cannot be applied to recovery of global systolic function. 
Furthermore, as outcome was dichotomized, we did not analyze the magnitude of 
changes in MPI during DSE as a predictor of the extent of recovered myocardium. 
Previous data from MI patients, however, have shown that there is a significant 
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correlation between the amount of myocardium showing a contractile reserve and the 
degree of change in MPI during dobutamine infusion [145].  
 
Temporal changes in ventricular function and residual myocardial damage 
Although based on different populations the results of studies II and IV exhibit some 
similarities. In Study IV, global systolic function and DTI-based diastolic indices of LV 
function were better in patients with subsequent functional recovery. Similar findings in 
Study II probably reflect the fact that patients with complete recovery of wall motion 
abnormalities represented a homogeneous group of patients with viable myocardium, 
whereas patients with persistent wall motion abnormalities constituted a mix of patients 
with viable as well as non-viable infarct regions. Recovery of LV function in patients 
with viability may explain the small improvement in LV systolic function seen over 
time in this group. Despite the differences in baseline systolic and diastolic parameters, 
MPI values did not differ significantly between groups, although absolute values were 
lower in patients with LV functional recovery. DTI-derived diastolic parameters 
improved over time in both groups in Study II, whereas in Study IV, diastolic function 
remained depressed at follow-up in patients without functional recovery. These 
findings are consistent with the results of previous studies, representing a phenomenon 
sometimes referred to as “diastolic stunning” [198]. The results of Study II show that 
despite normalized standard echocardiographic parameters of LV function, systolic and 
diastolic LV velocities in MI patients are significantly reduced compared with those in 
healthy subjects, possibly representing residual subendocardial damage. At the opposite 
end of the temporal spectrum, reduced myocardial velocities have been shown to 
represent very early stages of heart disease, possibly preceding clinical manifastation 
by years [199]. This ability to predict development of disease may be useful for risk 
assessment and timing of intervention. The clinical value of retrospective findings such 
as the reduced myocardial velocities observed in Study II however, is probably limited. 
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CONCLUSIONS 
The purpose of this study was to evaluate the use of myocardial velocity data from PW 
DTI as quantitative markers of LV and RV function at rest and during dobutamine 
stress in patients with STEMI. Recording and calculation of velocities and time 
intervals was shown to be feasible with reasonable inter- and intraobserver variability.  
 
The results of the study suggest that: 
 
• Peak RV systolic myocardial velocity is a sensitive marker of RV infarction, 
allowing assessment of RV function in the early as well as the late phase after a 
first STEMI. 
 
• Analysis of changes in the myocardial performance index during dobutamine 
stress echocardiography identifies the presence of coronary artery disease, even 
at suboptimal levels of stress. 
 
• A decrease in MPI during low-dose dobutamine infusion predicts recovery of 
regional left ventricular function over time.  
 
• Improvement of diastolic function is parallel to recovery of systolic function 
and is restricted to patients with viable myocardium. 
 
• Despite normalized standard echocardiographic parameters of LV function, 
systolic and diastolic myocardial velocities remain reduced compared with 
healthy subjects at late follow-up, possibly representing residual myocardial 
damage. 
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